Expression of epithelial-mesenchymal transition markers in locally recurrent hepatocellular carcinoma after radiofrequency ablation

Experimental and Therapeutic Medicine

Volumn 1, Issue 2, 2010, Pages 347-350

  Tajima, Hidehiro ^a   Ohta, Tetsuo ^a   Shoji, Yasuhiro ^a   Watanabe, Totoshifumi ^a   Makino, Isamu ^a   Hayashi, Hironori ^a   Nakagawara, Hisatoshi ^a   Onishi, Ichiro ^a   Takamura, Hiroyuki ^a   Ninomiya, Itasu ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Tani, Takashi ^a   Fujimura, Takashi ^a   Kayahara, Masato ^a   Arai, Kuniaki ^a   Yamashita, Tatsuya ^a   Kaneko, Shuichi ^a   Zen, Yoh ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Epithelial mesenchymal transition; Hepatocellular carcinoma; Local recurrence; Radiofrequency ablation

Indexed keywords

NERVE CELL ADHESION MOLECULE; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; RADIOFREQUENCY ABLATION; TUMOR DIFFERENTIATION;

EID: 77956197188     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000054     Document Type: Article

References (30)

1. Rossi S, Garbagnati F, Lencinoni R, et al: Percutaneous radio-frequency thermal ablation of non-resectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217: 119-126, 2000.
2. Livraghi T, Goldberg SN, Lazzaroni S, et al: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210: 655-661, 1999.
3. Allgaier HPHP, Deibert P, Zuber I, et al: Percutaneous radio-frequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 353: 1676-1677, 1999.
4. Nicoli N, Casaril A, Marchiori L, et al: Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital 52: 29-40, 2000.
5. Nicoli N, Casaril A, Marchiori L, et al: Treatment of recurrent hepatocellular carcinoma by radio-frequency thermal ablation. J Hepatobil Pancreat Surg 8: 417-421, 2001.
6. Solbaiati L, Livraghi T, Goldberg SN, et al: Percutaneous radio-frequency ablation of hepatic metastasis from colorectal cancer: long-term result in 117 patients. Radiology 221: 159-166, 2001.
7. Steven ACAC, Francesco I, Lee ME, Nicolas V and Paolo V: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232: 381-391, 2000.
8. Vivarelli M, Guglielmi A, Ruzzenente A, et al: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 204: 102-107, 2004.
9. Nicola N, Andrea C, Moh'd AH, et al: A case of rapid intrahepatic dissemination of hepatocellular cartinoma after radiofrequency thermal ablation. Am J Surg 188: 165-167, 2004.
10. Nazario P, Guido AMT, Maurizio R, et al: Aggressive recurrence after radiofrequency ablation of liver neoplasms. Hepatogastroenterology 50: 2179-2184, 2003.
11. Takada Y, Kurata M and Ohkohchi N: Rapid and aggressive recurrence accompanied by portal tumor thrombus after radio-frequency ablation for hepatocellular carcinoma. Int Clin Oncol 8: 332-335, 2003.
12. Tajima H, Ohta T, Okamoto K, et al: Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma. Oncol Lett 1: 91-94, 2010.
13. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.
14. Hay ED and Zuk A: Transformations between epithelium and mesenchyme: normal, pathological and experimentally induced. Am J Kidney Dis 26: 678-690, 1995.
15. Koda M, Maeda Y, Matsunaga Y, et al: Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res 27: 163-167, 2003.
16. Soo K, O'Rourke MPMP, Khoo PLPL, et al: Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev Biol 247: 251-270, 2002.
17. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996.
18. Du GS, Lu JX, Ma CQ, et al: Expression of P-aPKC-I, E-cadherin and β-catenin related to invasion and metastasis in hepatocellular carcinoma. Ann Surg Oncol 16: 1578-1586, 2009.
19. Perl AK, Wilgenbus P, Dahl U, et al: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193, 1998.
20. Hatta K and Takeichi M: Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 320: 447-449, 1986.
21. Seo DD, Lee HC, Kim HJ, et al: Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients. J Gastroenterol Hepatol 23: 1112-1118, 2008.
22. Hazan RB, Qiao R, Keren R, Badano I and Suyama K: Cadherin switch in tumor progression (Review). Ann NY Acad Sci 1014: 155-163, 2004.
23. Ihara A, Koizumi H, Hashizume R and Uchikoshi T: Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23: 1441-1447, 1996.
24. Kakizoe S, Kojiro M and Nakashima T: Hepatocellular carcinoma with sarcomatous change. Cancer 59: 310-316, 1987.
25. Park MY, Kim K, Park HS, et al: Expression of the serum response factor in hepatocellular carcinoma: Implications for epithelial-mesenchymal transition. Int J Oncol 31: 1309-1315, 2007.
26. Takamoto H, Shibata K, Kajiyama H, et al: Irradiation-induced epithelial-mesencymal transition (EMTMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 107: 500-504, 2007.
27. Yang AD, Fan F, Camp ER, et al: Chronic oxaliplatin resistance induces epithelial-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147-4153, 2006.
28. Yang SD, Lee SC and Chang HC: Heat stress induces tyrosine phosphorylation/activation of kinase FA/GSK-3 alpha (a human carcinoma dedifferentiation modulator) in A431 cells. J Cell Biochem 66: 16-26, 1997.
29. Obara K, Matsumoto N, Okamoto M, et al: Insuffcient radio-frequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int 2: 116-123, 2008.
30. Llovet JM, Vilana R, Brú C, et al: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33: 1124-1129, 2001.